A conceptual model of food cue reactivity, Nutrients (2023) Human drug compounding, Food and Drug Administration (2024) Compounding when drugs are on FDAs drug shortages list, Food and Drug Administration (2024) Your guide to FDA-approved medicines that contain semaglutide, Novo Nordisk FDA alerts health care providers, compounders, and patients of dosing errors associated with compounded injectable semaglutide products, Food and Drug Administration (2024) FDAs concerns with unapproved GLP-1 drugs used for weight loss, Food & Drug Administration (2024) Wegovy, DailyMed (2024) FDA warns patients and health care professionals not to use compounded drugs from Fullerton Wellness, Food and Drug Administration (2024) Novo Nordisk escalates legal actions to safeguard patients from potentially harmful compounded semaglutide drugs, Novo Nordisk (2024) FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, Food and Drug Administration (2025) OFA v

A more strategic clinical decision is to maintain the GLP-1 at a tolerable maintenance dose to control appetite, and introduce a complementary mechanism
This exclusivity allows the brand-name manufacturer to recoup research and development costs before facing generic competition
Use an open container within 3 to 5 days in the refrigerator, 1 to 2 days in a cold room, or a few hours in a warm room